Role of intranasal midazolam as a procedural sedative in children aged 6 months to 12 years: An open-label randomized controlled study. Indian Journal of Child Health, [S. l.], v. 5, n. 1, p. 1–5, 2018. DOI: 10.32677/IJCH.2018.v05.i01.001. Disponível em: https://mansapublishers.com/index.php/ijch/article/view/678.. Acesso em: 22 nov. 2024.